IDC Report: Huawei Ranks No.1 in Global Wrist-Worn Market in Q1
SHENZHEN, China, June 14, 2025 /PRNewswire/ -- According to the latest IDC Worldwide Quarterly Wearable Device Tracker data, Huawei ascended to the top position in the global wrist-worn device market in Q1 2025, while maintaining robust growth momentum and retaining its leadership in shipment volume within China. Additionally, as of 5 June 2025, Huawei's cumulative global wearable shipments have exceeded 200 million units.
Five Product Series Catering to Global Users' Diverse Scenario Needs
Huawei wearables integrate fashionable design, professional and comprehensive sports and health features, and efficient, practical smart experiences. Tailored to different user needs, Huawei has developed five product series to fulfil the diverse scenario requirements of all user groups—spanning smart living, scientific exercise, and health management.
The HUAWEI WATCH Series incorporates cutting-edge smart technology, featuring standalone calling capabilities and smart vehicle control functions to enable an efficient, intelligent lifestyle. The newly launched HUAWEI WATCH 5 delivers enhanced intelligence, efficiency and convenience. Equipped with the innovative multi-sensing X-TAP technology, it unlocks new dimensions in health monitoring and tactile interaction. The HUAWEI WATCH FIT Series fulfils lightweight wear needs through its slim design and extensive sports functions, allowing users to fully enjoy daily life. Meanwhile, the HUAWEI WATCH GT Series combines exceptional battery life with fashionable aesthetics and professional sports health features, serving as a comprehensive wrist-worn fitness coach.
For users who push boundaries and challenge extremes, the HUAWEI WATCH Ultimate Series delivers ultimate reliability with its rugged construction, advanced sports modes including 100-metre professional diving and outdoor expedition features, as well as advanced golf course mode, to bring cater to users' needs.
Additionally, addressing hypertension management challenges, Huawei innovatively broke through wrist-based blood pressure technology to launch the HUAWEI WATCH D Series. Through its breakthrough 24-hour dynamic blood pressure monitoring function, it helps users measure and manage blood pressure anytime, anywhere, integrating professional-grade blood pressure health guardianship into daily life.
Technological Innovation Driving Breakthroughs in Sports Health Technology
Behind the satisfaction of users' sports health management needs lies Huawei wearables' continuous innovation investment. Huawei has established three Health Labs globally, leveraging capabilities from over ten Huawei research institutes to relentlessly explore the frontiers of sports health technology.
In 2024, Huawei launched its new digital health & fitness paradigm—TruSense System—achieving higher accuracy and speed in vital sign data monitoring. In 2025, the TruSense System was upgraded again, fusing the advantages of fingertip and wrist detection to deliver a fuller, more accurate, and faster health monitoring experience, including 10-second fingertip blood oxygen readings and an increase in micro-body measurement indicators to 17 items.
In the field of blood pressure management, Huawei pioneered the launch of the HUAWEI WATCH D, a wrist-based blood pressure monitor that obtained Class II medical device registration certification in China. Now this innovation included in the "Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision)".
As of now, Huawei wearable devices have obtained 7 domestic medical certifications and medical device certificates in 13 overseas countries/regions, with nearly 1000 patent applications in the smart wearables field.
Huawei has collaborated with over 160 global professional institutions, conducted 300+ health research projects, and attracted over 17 million users to participate in health studies.
Huawei accompanies global users to build sports health lifestyles together. In September 2023, Huawei initiated the "Light Up Your Rings" campaign, which has seen over 6 million global users participate, lighting up rings over 300 million times. In 2025, the fully upgraded "Active Rings" initiative was introduced, inspiring global users to move joyfully anytime, anywhere with Huawei wearables.
The Active Rings campaign has already been held in Germany, Spain, and China, and beyond, where consumers jointly enjoyed active moments. It will progressively launch in APAC, Latin America, the Middle East, and other regions in the future.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
2 hours ago
- Korea Herald
Medit to Reveal New Medit i900 Mobility, Powered by True Mobility
SEOUL, South Korea, Aug. 1, 2025 /PRNewswire/ -- Medit ( a global leader in digital dentistry, today introduces the Medit i900 Mobility, a next-generation intraoral scanner designed to deliver simplicity and true mobility to clinical workflows. The Medit i900 Mobility is the latest addition to Medit's scanner lineup, thoughtfully designed to move with the pace of everyday dentistry, wherever care happens. At the heart of the experience are four core pillars of mobility: improved clinical efficiency and workflow fluidity optimized for chair-to-chair and room-to-room use, instant usability with lite installation, enhanced patient interaction during the scanning process and a minimal learning curve that makes adoption easy from the first scan. The i900 Mobility transforms how clinicians work, move and connect with patients by combining precision with ease of use. At the core of this experience is Medit Link Express, the company's first iPad-native companion app, designed to simplify scan-and-send workflows through an intuitive, user-friendly interface. With real-time scan viewing and built-in patient engagement, the app transforms the iPad into a seamless bridge between clinician and patient — immediate, effortless and mobile. Purpose-built for flexibility, the i900 Mobility pairs best-in-class software with compact, responsive hardware, ready to support chairside scanning, team collaboration and care beyond the traditional clinic setting. Designed for a new standard of mobility, key highlights of the i900 Mobility include: Together, the i900 Mobility and Medit Link Express redefine what mobility means in dentistry, reshaping how scanning fits into everyday practice. Whether at the chairside, between clinical staff, easily moving between environments, or stepping beyond the traditional clinic, it's a more fluid, responsive way to work. This is scanning, powered by true mobility. Pre-orders for the Medit i900 Mobility open August 1, 2025, with shipping set to begin from September 1, availability may vary by region. Medit Link Express will be available for download from the Apple App Store starting September 1. For more information and updates, visit About Medit Medit is a global provider of 3D intraoral scanners and digital dentistry solutions based on proprietary technology. The company supports collaborative workflows between dental clinics and labs through innovative hardware and software solutions. Headquartered in Seoul, South Korea, since 2000, Medit has a strong global presence through its offices in the Americas and Europe and a distributor network spanning over 100 countries.
Korea Herald
11 hours ago
- Korea Herald
e& reports 60.7% increase in consolidated net profit, reaching AED 8.8 billion in H1 2025
ABU DHABI, UAE, July 31, 2025 /PRNewswire/ -- e& today announced its consolidated financial results for the first half of 2025, reporting continued growth momentum and strategic progress across its business pillars. e&'s performance reinforces the Group's position as a global technology leader, driving digital transformation at scale across regional and international markets. Consolidated revenue increased to AED 34.9 billion, representing a year-over-year growth of 23.3 per cent compared to H1 2024. Consolidated net profit in H1 rose to AED 8.8 billion, up 60.7 per cent from the previous year. EBITDA in H1 reached AED 15.4 billion, a YoY increase of 18.8% with EBITDA margin of 44.1 per cent. The Group's subscriber base grew to 198 million globally, marking a 13.1 per cent increase year-over-year. In the UAE, e& UAE subscribers reached 15.5 million, driven by rising demand for advanced connectivity solutions, AI-powered services, and tailored digital experiences that address the evolving needs of both individuals and businesses. Key Financial Highlights for H1 2025 H.E. Jassem Mohamed Bu Ataba Alzaabi, Chairman, e&, said: "In the first half of 2025, e& continued to strengthen its leadership position, driven by its strategic investments and robust business model. Our continued strong performance reflects our commitment to long-term value creation, with major milestones reflecting the Board's strategic foresight. "In H1, e& continued its growth trajectory, delivering consolidated revenue of AED 34.9 billion—a year-on-year increase of 23.3 per cent—and achieving consolidated net profits of AED 8.8 billion, up 60.7 per cent compared to the same period last year. Alongside our outstanding financial performance, we maintained our focus on bringing the latest technologies to best serve our customers. We launched the UAE Sovereign Cloud Launchpad alongside AWS and the UAE Cybersecurity Council. This landmark initiative advances national priorities around digital sovereignty, secure AI, and cloud innovation, and is set to unlock enduring value for the nation's digital economy. "Thanks to the UAE's visionary leadership that inspires us, e& will continue enabling the knowledge economy with responsibility and ambition. We remain committed to shaping resilient, inclusive, and innovation-led societies across the markets we serve." Hatem Dowidar, Group Chief Executive Officer, e&, said:"e& delivered strong performance in the first half of 2025, reflecting our agility, innovation, and ability to scale. We preserved the momentum witnessed across our different verticals. Our diverse revenue streams enabled the group to drive financial success and deliver robust operational growth. Revenues in Q2 and H1 increased by 28.1 per cent year-over-year to AED 18.0 billion and by 23.3 per cent to AED 34.9 billion, respectively. Our EBITDA grew by 18.8 per cent to AED 15.4 billion in the first half. These results demonstrate the strength of our transformation strategy and our continued focus on operational excellence and value creation. "We achieved a series of strategic milestones, including the divestment of Khazna and partial divestment of Airalo during the first half of the year, which enhanced our financial flexibility. In parallel, we introduced the UAE Sovereign Cloud Launchpad, reinforcing our focus on secure, sovereign AI solutions. We also became one of the first companies to earn the 'Tier S' designation under the Dubai AI Seal, a top-level recognition of our leadership in responsible AI development and deployment. Additionally, we advanced our international footprint through the acquisition of Serbia Broadband, while our collaboration with Qualcomm is accelerating 5G evolution and edge AI integration across key industries. "Our progress was further recognised internationally, with e& named the world's Fastest Growing Brand by Brand Finance. This recognition reflects our bold ambition, customer-centric innovation, and growing global presence. "As we look ahead, we remain focused on enabling future technologies and delivering lasting impact across the communities we serve."
Korea Herald
13 hours ago
- Korea Herald
Neurophet Showcases Full-Cycle Brain Imaging Analysis Solutions for Alzheimer's disease Including 'Neurophet AQUA AD' at AAIC 2025
SEOUL, South Korea, July 31, 2025 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced on the 31st that it participated in the Alzheimer's Association International Conference (AAIC 2025), showcasing its flagship brain imaging analysis AI solutions. At the conference, Jake Junkil Been, Co-CEO of Neurophet, delivered a presentation titled "Neurophet in the Era of Paradigm Shift in Alzheimer's Disease: The Journey to IPO and Beyond," introducing the company's vision and roadmap. During the event, Neurophet introduced Neurophet AQUA AD, neuroimaging analysis software designed to monitor the prescription, treatment effects, and side effects of amyloid-targeted therapeutics for Alzheimer's disease. Neurophet AQUA AD quantitatively analyzes MRI (Magnetic Resonance Imaging) and PET (Positron Emission Tomography) scans, providing precise brain imaging analysis across the entire treatment process involving anti-amyloid antibody therapies. As the pharmaceutical and biotech industries accelerate the development of Alzheimer's disease treatments, the importance of adopting solutions that can precisely manage prescription, therapeutic efficacy, and potential side effects is increasingly coming into focus. Especially with Alzheimer's disease drugs such as Leqembi® (lecanemab) and Kisunla® (donanemab) requiring close monitoring of side effects, global demand and expectations are rising for Neurophet AQUA AD, a solution capable of analyzing brain imaging biomarkers related to adverse effects. At its exhibition booth, Neurophet is showcasing several key products, including Neurophet AQUA AD, Neurophet AQUA—a brain neurodegeneration imaging analysis software—and Neurophet SCALE PET, a quantitative analysis software for PET imaging. Through its participation in AAIC 2025, Neurophet is engaging in partnering efforts with global pharmaceutical companies and potential clients to pursue business development collaborations. The company is also holding meetings with leading Key Opinion Leaders (KOLs) in the field of neurology to highlight the unique strengths of its products and to build strategic collaborative networks. Jake Junkil Been, Co-CEO of Neurophet said that "Neurophet AQUA AD is gaining attention as a collaborative partner among various Korean and international companies in the field of brain imaging biomarkers," adding, "Through our participation in AAIC 2025, we plan to further accelerate global development collaborations for Neurophet AQUA AD and our other key products." AAIC 2025 is an international conference attended by dementia researchers and neurology clinicians, held in Toronto, Canada. This year's conference runs for five days, from July 27 to 31 (local time in Canada). About Neurophet Neurophet specializes in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain disorders based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Co-CEOs Jake Junkil Been and Donghyeon Kim, who developed the next-generation neuro-navigation system. Major products include brain MRI analysis software "Neurophet AQUA", PET Image Quantitative Analysis Software "Neurophet SCALE PET", Brain imaging treatment planning software for electric and magnetic brain stimulation "Neurophet tES/TMS LAB", Alzheimer's Disease treatment prescription and monitoring software "Neurophet AQUA AD" for tracking treatment efficacy and side effects, and Multiple Sclerosis image analysis software "Neurophet AQUA MS". Neurophet has set its top priority to helping patients suffering from brain disorders. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain's health and pioneer solutions for brain diseases with AI technology.
